Discover
ADIL
Adial Pharmaceuticals, Inc.
4.86
1 x 4.91
1 x 3.08
bid
ask
-
0.20
3.95%
1 @ 07:30 PM
4.86 +0.00 (0.00%)
| Ytd | -11.64% | |
| 1y | -44.46% |
4.59
day range
5.23
1.36
52 week range
10.50
| Open | 5.23 | Prev Close | 5.06 | Low | 4.59 | High | 5.23 | Mkt Cap | 14.26M |
| Vol | 86.98K | Avg Vol | 62.20K | EPS | -17.71 | P/E | N/A | Forward P/E | -0.79 |
| Beta | 1.30 | Short Ratio | 0.65 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.45 | 200-d Avg | 3.63 | 1yr Est | 7.50 |
| Income Statement | |||
| Operating Expenses | 52.03M | ||
| Research and Development Expense | 440.00K | ||
| Selling, General and Administrative Expense | 5.40M | ||
| Operating Income | -52.02M | ||
| Net Income | -51.99M | ||
| Net Income Common Stock | -51.99M | ||
| Net Income Common Stock (USD) | -51.99M | ||
| Consolidated Income | -51.99M | ||
| Earnings per Basic Share | -11.25 | ||
| Earnings per Basic Share (USD) | -11.25 | ||
| Earnings per Diluted Share | -11.25 | ||
| Earning Before Interest & Taxes (EBIT) | -51.99M | ||
| Earning Before Interest & Taxes (USD) | -51.99M | ||
| Weighted Average Shares | 4.62M | ||
| Weighted Average Shares Diluted | 4.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.71M | ||
| Cash and Equivalents (USD) | 28.71M | ||
| Investments | 241.00K | ||
| Investments Non-Current | 241.00K | ||
| Current Assets | 28.85M | ||
| Total Assets | 29.09M | ||
| Current Liabilities | 5.12M | ||
| Total Liabilities | 28.93M | ||
| Accumulated Retained Earnings (Deficit) | -143.98M | ||
| Shareholders Equity | -38.38M | ||
| Shareholders Equity (USD) | -38.38M | ||
| Assets Non-Current | 244.00K | ||
| Goodwill and Intangible Assets | 3.00K | ||
| Liabilities Non-Current | 23.81M | ||
| Trade and Non-Trade Payables | 2.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -141.00 | ||
| Net Cash Flow from Financing | 25.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 24.13M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 5.28M | ||
| Issuance (Purchase) of Equity Shares | 27.65M | ||
| Net Cash Flow from Investing | 5.28M | ||
| Net Cash Flow from Operations | -6.36M | ||
| Share Based Compensation | 137.10K | ||